These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6109932)

  • 1. Sex hormone binding globulin levels and prognosis in early breast cancer.
    Harris AL; Smith IE; Dowsett M; Jeffcoate SL; Coombes RC; Powles TJ; Neville AM
    Lancet; 1981 Jan; 1(8214):279. PubMed ID: 6109932
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex-hormone-binding globulin and oestrogen receptors.
    Mason RC; Miller WR; Hawkins RA; Forrest AP
    Biochem Soc Trans; 1981 Feb; 9(1):97-8. PubMed ID: 7194198
    [No Abstract]   [Full Text] [Related]  

  • 3. Are estrogen receptor content in breast cancer and effects of tamoxifen on sex hormone-binding globulin markers for individual estrogen sensitivity?
    Löfgren L; von Schoultz E; Fernstad R; von Schoultz B; Carlström K
    J Steroid Biochem Mol Biol; 2006 Apr; 99(1):76-9. PubMed ID: 16621526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone-binding globulin and estrogen receptor in breast cancer: technique and preliminary clinical results.
    Murayama Y; Sakuma T; Udagawa H; Utsunomiya J; Okamoto R; Asano K
    J Clin Endocrinol Metab; 1978 Jun; 46(6):998-1006. PubMed ID: 263661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma sex hormone binding globulin and tumour oestrogen receptor status in breast cancer patients.
    Lancet; 1981 Mar; 1(8220 Pt 1):617-8. PubMed ID: 6110852
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of antiestrogen drugs on the sex hormone and sex hormone-binding globulin levels in breast cancer patients.
    Számel I; Hindy I; Vincze B; Kerpel-Fronius S; Eckhardt S
    Ann N Y Acad Sci; 1988; 538():265-79. PubMed ID: 2973277
    [No Abstract]   [Full Text] [Related]  

  • 7. Sex hormone binding globulin as a reliable indicator of hormone dependence in human breast cancer.
    Murayama Y; Utsunomiya J; Takahashi I; Kitamura M; Tominaga T
    Ann Surg; 1979 Aug; 190(2):133-8. PubMed ID: 572661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-hormone-binding globulin predicts response of breast cancer to hormone therapy.
    Murayama YI; Utsunomiya J; Asano KI
    Lancet; 1977 Dec 24-31; 2(8052-8053):1356. PubMed ID: 74760
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors that may influence the estradiol receptor assay in human tissues:sex hormone binding globulin and endogenous steroids.
    Hähnel R; Twaddle E
    J Steroid Biochem; 1979 Jan; 10(1):95-8. PubMed ID: 574598
    [No Abstract]   [Full Text] [Related]  

  • 10. Androgen-estrogen production rates in postmenopausal women with breast cancer.
    Kirschner MA; Cohen FB; Ryan C
    Cancer Res; 1978 Nov; 38(11 Pt 2):4029-35. PubMed ID: 568029
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sex hormone-binding globulin in breast cancer].
    Suminaga Y; Morimoto T; Komaki K; Mori T; Monden Y
    Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):875-82. PubMed ID: 2398880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex hormone binding globulin in breast cancer.
    Bowen M; Ward AM; Humphreys J; Coombes RC
    Ric Clin Lab; 1980; 10(4):591-5. PubMed ID: 7193905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of treatment with tamoxifen on serum levels of various steroid and protein hormones in women with breast cancer].
    Grodecka-Gazdecka S; Kociałkowski K; Chwalisz K; Baron J
    Endokrynol Pol; 1985; 36(6):341-8. PubMed ID: 3833535
    [No Abstract]   [Full Text] [Related]  

  • 14. [Competitive binding assay with dextran-coated charcoal for measurement of sex hormone-binding globulin in breast cancer].
    Suminaga Y; Sonoo H; Morimoto T
    Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):341-9. PubMed ID: 2423861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Steroid-binding protein levels in breast cancer patients].
    Bezrukavnikova NV; Kokhanov AV; Kriventsev IuA; Nikulina DM; Bershteĭn LM; Kutukov VV
    Vopr Onkol; 2007; 53(4):409-13. PubMed ID: 17969402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between sex hormone binding globulin and estrogen receptors in breast cancer.
    Plymate SR; Stutz FH; Fariss BL
    J Clin Oncol; 1984 Jun; 2(6):652-4. PubMed ID: 6539364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical study of cytosolic estrogen receptor-bound protein in breast cancer. Correlation with a biochemical study. Apropos of 107 surgical specimens].
    Vildé F; Arkwright S
    Arch Anat Cytol Pathol; 1992; 40(1-2):7-11. PubMed ID: 1605702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones.
    Moore JW; Key TJ; Bulbrook RD; Clark GM; Allen DS; Wang DY; Pike MC
    Br J Cancer; 1987 Nov; 56(5):661-6. PubMed ID: 3426933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor assay of mammary carcinomas. Effects of testosterone-estradiol-binding globulin (TeBG) and serum estradiol-17 beta.
    Meyer JS; Stevens SC; Vandillen N; White WL
    Am J Clin Pathol; 1979 Oct; 72(4):564-70. PubMed ID: 573965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.